Archive of Postings to PHARM-POLICY Sorted by Thread
[Prev Page][Next Page]
- Who owns your genes and body parts,
James Love
- Glaxo Wellcom and SmithKline Beechman merger,
James Love
- FTAA sign-on IP position paper,
James Love
- Bolar Roche,
James Love
- Bolar exemption,
James Love
- PhrMA v Zuma in South Africa,
James Love
- Generic Drug Policy in Mexico under fire from PhRMA,
James Love
- University Sponsored medical Research,
James Love
- May 7-8 meeting on Health and IPR,
James Love
- ISREAL: New debate about "Barriers to entry of generic drugs",
James Love
- FDA Letter on Generic Drugs,
James Love
- US Supreme Court: Parallel Imports of copyrighted goods are OK,
James Love
- Gene Research,
James Love
- E-DRUG: HIV trials in developing countries,
James Love
- May 7-8, 1998 Workshop on Intellectual Property, Health Care and International Trade Agreements,
James Love
- Medicines & Related Substances Control Amendment Act,
James Love
- FTAA Business Forum closes meetings to public, press and NGOs,
James Love
- Daley Zuma Meeting Regarding Drug Law,
James Love
- WHA: EBl0l.R24, Revised drug strategy,
James Love
- Boston Globe Report on Government funded R&D and pharmaceutical,
James Love
- Patent-news on Biopatents and the Third World,
James Love
- Amgen, EPO and US Pat. 5,625,035,
James Love
- Top 10 selling prescription drugs,
James Love
- New URL for Boston Globe Story,
James Love
- Essential Facilities Decision in Intel Case,
James Love
- NIH and Biotech Sector,
James Love
- EPO Background from Amgen 10k,
James Love
- Investigation of Amgen suppression of EPO invention,
James Love
- Letters to Clinton and Binder Re: EPO,
James Love
- Workshop on Intellectual Property,Health Care and International Trade Agreements,
James Love
- Reuters story on Amgen EPO,
James Love
- Wired on Amgen EPO Dispute,
James Love
- Amgen comments on EPO invention,
James Love
- Correction and addition,
James Love
- Drug makers may get six months extra patent life,
James Love
- WSJ Journal to Issue Retraction,
James Love
- Letter to Editor, WSJ,
James Love
- correction on date of WSJ correction,
James Love
- USTR's 301 Watch lists On the Web,
James Love
- Health Care and USTR IPR "Watch List",
James Love
- Meeting Agenda - Workshop on Health Care, IP and Trade Agreements,
James Love
- WHO resolution - Action taken etc.,
consumer unity CUTSCAL trust society
- World Health Assembly Resolution on TRIPS and Public Health,
James Love
- Health Care and Trade Negotiations Letter to Department of State,
James Love
- Guardian article on Meningitis Patent,
James Love
- Compulsory Licensing Backgrounder,
James Love
- Government Funded Drugs,
James Love
- New Zealand lifts ban on parallel imports -- US Objects,
James Love
- CPT Comments to USTR Regarding FTAA Negotiations -- Health Care comments,
James Love
- 1990 Thai Tobacco case --- as precedent for WHA resolution,
James Love
- Sneak Prescription Drug Patent Extension,
James Love
- public comments on WTO,
Catherine Gavin
- CPT's page on Health Care and the World Health Organization,
Catherine Gavin
- AIDS and compulsory licensing,
James Love
- Aid for AIDS in Zimbabwe,
James Love
- Time Magazine on Corporate Welfare and patent extensions,
James Love
- Sneak Prescription Drug Patent Extension in Appropriations Rider,
James Love
- Congressinal Report on Prescription Drug Pricing in the US,
James Love
- Mylan price fixing suit,
James Love
- NCI Role in the Development of 37 Cancer Drugs,
James Love
- US to support WHA Revised Drug Strategy,
James Love
- FTC changes Myland with Restrain of Trade, Conspiracy and Monopolization,
James Love
- Fwd: Fwd: marketing medicines through RCT's,
A Pieters
- Africa: Women and AIDS,
James Love
- Parallel Imports in EU - from E-Drug,
James Love
Mail converted by MHonArc 2.3.3